Article Details

RNAi therapeutic shows promise in protection against NASH

Retrieved on: 2021-06-26 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

RNAi therapeutic shows promise in protection against NASH. View article details on hiswai:

Excerpt

“ARO-HSD (Arrowhead Pharmaceuticals) is an RNA interferon based therapeutic designed to selectively target HSD17B13 in mRNA in hepatocytes, ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up